119 related articles for article (PubMed ID: 9223658)
1. Inhibition of growth in oral squamous carcinoma cells by cyclopentenone prostaglandins: comparison with chemotherapeutic agents.
ElAttar TM; Virji AS
Prostaglandins Leukot Essent Fatty Acids; 1997 Jun; 56(6):461-5. PubMed ID: 9223658
[TBL] [Abstract][Full Text] [Related]
2. Vitamin E succinate potentiates the inhibitory effect of prostaglandins on oral squamous carcinoma cell proliferation.
elAttar TM; Lin HS
Prostaglandins Leukot Essent Fatty Acids; 1995 Jan; 52(1):69-73. PubMed ID: 7708823
[TBL] [Abstract][Full Text] [Related]
3. Targeting of epidermal growth factor receptor by cyclopentenone prostaglandin 15-Deoxy-Delta12,14-prostaglandin J2 in human oral squamous carcinoma cells.
Siavash H; Nikitakis NG; Sauk JJ
Cancer Lett; 2004 Jul; 211(1):97-103. PubMed ID: 15194221
[TBL] [Abstract][Full Text] [Related]
4. Effects of indomethacin, cisplatin and delta 12-prostaglandin J2 on growth of oral squamous carcinoma cells.
el Attar TM; Virji AS
Anticancer Res; 1997; 17(6D):4399-402. PubMed ID: 9494540
[TBL] [Abstract][Full Text] [Related]
5. Inhibitory properties of antitumor prostaglandins against topoisomerases.
Suzuki K; Uyeda M
Biosci Biotechnol Biochem; 2002 Aug; 66(8):1706-12. PubMed ID: 12353631
[TBL] [Abstract][Full Text] [Related]
6. The role of c-Myc and heat shock protein 70 in human hepatocarcinoma Hep3B cells during apoptosis induced by prostaglandin A2/Delta12-prostaglandin J2.
Ahn SG; Jeong SY; Rhim H; Kim IK
Biochim Biophys Acta; 1998 Nov; 1448(1):115-25. PubMed ID: 9824682
[TBL] [Abstract][Full Text] [Related]
7. Functional antagonism between IL-2 and PGA1 or PGJ2 in the control of proliferation of human cord blood-derived mononuclear cells.
Franzese O; Bonmassar E; Marcucci A; D'Onofrio C
Int J Immunopharmacol; 1996 Nov; 18(11):609-22. PubMed ID: 9089005
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of human melanoma growth by prostaglandin A, D, and J analogues.
Bregman MD; Funk C; Fukushima M
Cancer Res; 1986 Jun; 46(6):2740-4. PubMed ID: 3698005
[TBL] [Abstract][Full Text] [Related]
9. N-myc suppression and cell cycle arrest at G1 phase by prostaglandins.
Marui N; Sakai T; Hosokawa N; Yoshida M; Aoike A; Kawai K; Nishino H; Fukushima M
FEBS Lett; 1990 Sep; 270(1-2):15-8. PubMed ID: 2226777
[TBL] [Abstract][Full Text] [Related]
10. Delta12-Prostaglandin J2 inhibits the ubiquitin hydrolase UCH-L1 and elicits ubiquitin-protein aggregation without proteasome inhibition.
Li Z; Melandri F; Berdo I; Jansen M; Hunter L; Wright S; Valbrun D; Figueiredo-Pereira ME
Biochem Biophys Res Commun; 2004 Jul; 319(4):1171-80. PubMed ID: 15194490
[TBL] [Abstract][Full Text] [Related]
11. Site and mechanism of growth inhibition by prostaglandins. I. Active transport and intracellular accumulation of cyclopentenone prostaglandins, a reaction leading to growth inhibition.
Narumiya S; Fukushima M
J Pharmacol Exp Ther; 1986 Nov; 239(2):500-5. PubMed ID: 3772804
[TBL] [Abstract][Full Text] [Related]
12. Biphasic action of vitamin E on the growth of human oral squamous carcinoma cells.
Elattar TM; Virji AS
Anticancer Res; 1999; 19(1A):365-8. PubMed ID: 10226568
[TBL] [Abstract][Full Text] [Related]
13. Comparative anti-viral and anti-proliferative activity of PGA1 and PGJ2 against HTLV-I-infected MT-2 cells.
D'Onofrio C; Amici C; Puglianiello A; Faraoni I; Lanzilli G; Santoro MG; Bonmassar E
Int J Cancer; 1992 May; 51(3):481-8. PubMed ID: 1592539
[TBL] [Abstract][Full Text] [Related]
14. p53-Independent activation of the gadd45 promoter by Delta12-prostaglandin J2.
Ohtani-Fujita N; Minami S; Mimaki S; Dao S; Sakai T
Biochem Biophys Res Commun; 1998 Oct; 251(2):648-52. PubMed ID: 9792828
[TBL] [Abstract][Full Text] [Related]
15. Stereoselective conjugation of prostaglandin A2 and prostaglandin J2 with glutathione, catalyzed by the human glutathione S-transferases A1-1, A2-2, M1a-1a, and P1-1.
Bogaards JJ; Venekamp JC; van Bladeren PJ
Chem Res Toxicol; 1997 Mar; 10(3):310-7. PubMed ID: 9084911
[TBL] [Abstract][Full Text] [Related]
16. [Resistance of isolated cells from squamous cell carcinomas of the oral cavity to cytotoxic drugs].
Eickbohm JE; Görögh T; Lippert B; Ewers R
Dtsch Z Mund Kiefer Gesichtschir; 1991; 15(6):405-9. PubMed ID: 1726315
[TBL] [Abstract][Full Text] [Related]
17. Suppressive effects of various antitumor prostaglandin derivatives on the activity levels of DNA polymerases in human cultured tumor cells.
Ono K; Nakane H; Kato T; Fukushima M
Adv Prostaglandin Thromboxane Leukot Res; 1987; 17B():976-80. PubMed ID: 2960215
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of poliovirus replication by prostaglandins A and J in human cells.
Conti C; Mastromarino P; Tomao P; De Marco A; Pica F; Santoro MG
Antimicrob Agents Chemother; 1996 Feb; 40(2):367-72. PubMed ID: 8834882
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of the proliferation of transformed epidermal cells in culture by various prostaglandins.
Ikai K; Ujihara M; Kashihara M; Fukushima M
J Invest Dermatol; 1987 Jul; 89(1):69-72. PubMed ID: 2439606
[TBL] [Abstract][Full Text] [Related]
20. Antiproliferative activity of cyclopentenone prostaglandins in early HTLV-1 infection is independent of IL-2 and is associated with HSP70 induction.
D'Onofrio C; Franzese O; De Marco A; Bonmassar E; Amici C
Leukemia; 1994 Jun; 8(6):1045-56. PubMed ID: 7516027
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
